Failure of SGLT-2 inhibitor in the context of new ileal conduit formation

被引：0
|
作者：
Almog, Joel [1 ,4 ]
Jain, Shalu [2 ]
Pybass, Phillip [3 ]
Gupta, Ankur [1 ]
机构：
[1] Te Whatu Ora Hlth New Zealand Midcent Dist, Dept Nephrol, Hamilton, New Zealand
[2] Te Whatu Ora Hlth New Zealand Midcent Dist, Diabet & Endocrinol Serv, Hamilton, New Zealand
[3] Te Whatu Ora Hlth New Zealand Midcent Dist, Dept Internal Med, Hamilton, New Zealand
[4] Palmerston North Hosp, Ground Floor,50 Ruahine St, Palmerston North 4442, New Zealand
来源：
NEW ZEALAND MEDICAL JOURNAL | 2023年 / 136卷 / 1571期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：83 / 85
页数：3
相关论文
共 50 条
  • [31] SGLT-2 Inhibitors - a Novel Treatment Option in Heart Failure
    Schuett, Katharina
    Berger, Martin
    Marx, Nikolaus
    AKTUELLE KARDIOLOGIE, 2021, 10 (04) : 297 - 301
  • [32] Heart Failure with low RR: no Reason to avoid SGLT-2
    Franke, Katharina
    AKTUELLE KARDIOLOGIE, 2022, 11 (01) : 14 - 14
  • [33] NEW DIRECTIONS IN PHARMACOLOGICAL TREATMENT WITH SGLT-2 INHIBITOR MOLECULES IN THE LIGHT OF CURRENT GUIDELINES FOR DIABETES MELLITUS, HEART FAILURE AND KIDNEY DISEASE
    Tilinca, Mariana Cornelia
    Antal, Csilla
    Salcudean, Andreea
    Abalasei, Bianca Larisa
    Farcas, Roxana Maria
    Grosan, Alexandra
    FARMACIA, 2023, 71 (04) : 686 - 696
  • [34] A Practical Stereoselective Synthesis and Novel Cocrystallizations of an Amphiphatic SGLT-2 Inhibitor
    Deshpande, Prashant P.
    Singh, Janak
    Pullockaran, Annie
    Kissick, Thomas
    Ellsworth, Bruce A.
    Gougoutas, Jack Z.
    Dimarco, John
    Fakes, Michael
    Reyes, Mayra
    Lai, Chiajen
    Lobinger, Hidegard
    Denzel, Theo
    Ermann, Peter
    Crispino, Gerard
    Randazzo, Michael
    Gao, Zenrong
    Randazzo, Renee
    Lindrud, Mark
    Rosso, Victor
    Buono, Frederic
    Doubleday, Wendel W.
    Leun, Simon
    Richberg, Pricilla
    Hughes, David
    Washburn, William N.
    Meng, Wei
    Volk, Kevin J.
    Mueller, Richard H.
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2012, 16 (04) : 577 - 585
  • [35] Combination therapy with an SGLT-2 inhibitor and finerenone in DKD: Are we there yet?
    Georgianos, Panagiotis, I
    Eleftheriadis, Theodoros
    Liakopoulos, Vassilios
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023, 53 (02)
  • [36] SGLT-2 inhibitor-related genital tract infections and UTIs
    Reactions Weekly, 2023, 1976 (1) : 10 - 10
  • [37] The outcomes of SGLT-2 inhibitor utilization in diabetic kidney transplant recipients
    Sheu, Jia-Yuh
    Chang, Li-Yang
    Chen, Jui-Yi
    Pan, Heng-Chih
    Tseng, Chi-Shin
    Chueh, Jeff S.
    Wu, Vin-Cent
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [38] Individualizing Treatment With SGLT-2 Inhibitor Therapy in Type 2 Diabetes Mellitus
    Miller, Eden M.
    JOURNAL OF FAMILY PRACTICE, 2017, 66 (02): : S13 - S16
  • [39] Fournier's Gangrene: A Coexistence or Consanguinity of SGLT-2 Inhibitor Therapy
    Chowdhury, Tutul
    Gousy, Nicole
    Bellamkonda, Amulya
    Dutta, Jui
    Zaman, Chowdhury F.
    Zakia, Ummul B.
    Tasha, Tasniem
    Dutta, Priyata
    Roy, Padmaja Deb
    Gomez, Adriana M.
    Mainali, Arjun
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [40] Use of SGLT-2 inhibitor in COVID-19: A cautionary tale
    Yousaf, Zohaib
    Munir, Waqar
    Hammamy, Riyadh Ali Mohammed
    MEDCOMM, 2021, 2 (01): : 114 - 116
12345